Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22)

Nozomu Kawashima, Akira Shimada, Takeshi Taketani, Yasuhide Hayashi, Nao Yoshida, Kimikazu Matsumoto, Yoshiyuki Takahashi, Seiji Kojima, Koji Kato

    Research output: Contribution to journalArticle

    6 Citations (Scopus)

    Abstract

    Acute myeloid leukemia with abnormal bone marrow eosinophilia (AML-M4Eo) is often reported in core binding factor (CBF) leukemia, with translocations such as inv(16)(p13q22), t(16;16)(p13;q22) or t(8;21)(q22;q22); however, it is rarely reported with t(16;21)(q24;q22), which produces the RUNX1-CBFA2T3 (AML1-MTG16) chimera. The similarity between this chimera and RUNX1-RUNXT1 (AML1-MTG8) by t(8;21)(q22;q22) remains controversial. Adult leukemia with t(16;21)(q24;q22) was primarily therapy related, and shows poor prognosis; however, pediatric AML with this translocation was quite rare and tended to be de novo AML. We present here a 4-year-old boy with de novo AML-M4Eo and t(16;21) (q24;q22). He received chemotherapy and survived for more than 70 months without transplantation. We speculated that pediatric AML with t(16;21)(q24;q22) showed favorable prognosis, as with t(8;21)(q22;q22).

    Original languageEnglish
    Pages (from-to)577-580
    Number of pages4
    JournalInternational journal of hematology
    Volume95
    Issue number5
    DOIs
    Publication statusPublished - May 1 2012

    Fingerprint

    Eosinophilia
    Acute Myeloid Leukemia
    Leukemia
    Core Binding Factors
    Bone Marrow
    Pediatrics
    Transplantation
    Drug Therapy
    Therapeutics

    All Science Journal Classification (ASJC) codes

    • Hematology

    Cite this

    Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22). / Kawashima, Nozomu; Shimada, Akira; Taketani, Takeshi; Hayashi, Yasuhide; Yoshida, Nao; Matsumoto, Kimikazu; Takahashi, Yoshiyuki; Kojima, Seiji; Kato, Koji.

    In: International journal of hematology, Vol. 95, No. 5, 01.05.2012, p. 577-580.

    Research output: Contribution to journalArticle

    Kawashima, N, Shimada, A, Taketani, T, Hayashi, Y, Yoshida, N, Matsumoto, K, Takahashi, Y, Kojima, S & Kato, K 2012, 'Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22)', International journal of hematology, vol. 95, no. 5, pp. 577-580. https://doi.org/10.1007/s12185-012-1044-7
    Kawashima, Nozomu ; Shimada, Akira ; Taketani, Takeshi ; Hayashi, Yasuhide ; Yoshida, Nao ; Matsumoto, Kimikazu ; Takahashi, Yoshiyuki ; Kojima, Seiji ; Kato, Koji. / Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22). In: International journal of hematology. 2012 ; Vol. 95, No. 5. pp. 577-580.
    @article{d55b4d83baea453cb04e0ed9b02f94f0,
    title = "Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22)",
    abstract = "Acute myeloid leukemia with abnormal bone marrow eosinophilia (AML-M4Eo) is often reported in core binding factor (CBF) leukemia, with translocations such as inv(16)(p13q22), t(16;16)(p13;q22) or t(8;21)(q22;q22); however, it is rarely reported with t(16;21)(q24;q22), which produces the RUNX1-CBFA2T3 (AML1-MTG16) chimera. The similarity between this chimera and RUNX1-RUNXT1 (AML1-MTG8) by t(8;21)(q22;q22) remains controversial. Adult leukemia with t(16;21)(q24;q22) was primarily therapy related, and shows poor prognosis; however, pediatric AML with this translocation was quite rare and tended to be de novo AML. We present here a 4-year-old boy with de novo AML-M4Eo and t(16;21) (q24;q22). He received chemotherapy and survived for more than 70 months without transplantation. We speculated that pediatric AML with t(16;21)(q24;q22) showed favorable prognosis, as with t(8;21)(q22;q22).",
    author = "Nozomu Kawashima and Akira Shimada and Takeshi Taketani and Yasuhide Hayashi and Nao Yoshida and Kimikazu Matsumoto and Yoshiyuki Takahashi and Seiji Kojima and Koji Kato",
    year = "2012",
    month = "5",
    day = "1",
    doi = "10.1007/s12185-012-1044-7",
    language = "English",
    volume = "95",
    pages = "577--580",
    journal = "International Journal of Hematology",
    issn = "0925-5710",
    publisher = "Springer Japan",
    number = "5",

    }

    TY - JOUR

    T1 - Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22)

    AU - Kawashima, Nozomu

    AU - Shimada, Akira

    AU - Taketani, Takeshi

    AU - Hayashi, Yasuhide

    AU - Yoshida, Nao

    AU - Matsumoto, Kimikazu

    AU - Takahashi, Yoshiyuki

    AU - Kojima, Seiji

    AU - Kato, Koji

    PY - 2012/5/1

    Y1 - 2012/5/1

    N2 - Acute myeloid leukemia with abnormal bone marrow eosinophilia (AML-M4Eo) is often reported in core binding factor (CBF) leukemia, with translocations such as inv(16)(p13q22), t(16;16)(p13;q22) or t(8;21)(q22;q22); however, it is rarely reported with t(16;21)(q24;q22), which produces the RUNX1-CBFA2T3 (AML1-MTG16) chimera. The similarity between this chimera and RUNX1-RUNXT1 (AML1-MTG8) by t(8;21)(q22;q22) remains controversial. Adult leukemia with t(16;21)(q24;q22) was primarily therapy related, and shows poor prognosis; however, pediatric AML with this translocation was quite rare and tended to be de novo AML. We present here a 4-year-old boy with de novo AML-M4Eo and t(16;21) (q24;q22). He received chemotherapy and survived for more than 70 months without transplantation. We speculated that pediatric AML with t(16;21)(q24;q22) showed favorable prognosis, as with t(8;21)(q22;q22).

    AB - Acute myeloid leukemia with abnormal bone marrow eosinophilia (AML-M4Eo) is often reported in core binding factor (CBF) leukemia, with translocations such as inv(16)(p13q22), t(16;16)(p13;q22) or t(8;21)(q22;q22); however, it is rarely reported with t(16;21)(q24;q22), which produces the RUNX1-CBFA2T3 (AML1-MTG16) chimera. The similarity between this chimera and RUNX1-RUNXT1 (AML1-MTG8) by t(8;21)(q22;q22) remains controversial. Adult leukemia with t(16;21)(q24;q22) was primarily therapy related, and shows poor prognosis; however, pediatric AML with this translocation was quite rare and tended to be de novo AML. We present here a 4-year-old boy with de novo AML-M4Eo and t(16;21) (q24;q22). He received chemotherapy and survived for more than 70 months without transplantation. We speculated that pediatric AML with t(16;21)(q24;q22) showed favorable prognosis, as with t(8;21)(q22;q22).

    UR - http://www.scopus.com/inward/record.url?scp=84862897867&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84862897867&partnerID=8YFLogxK

    U2 - 10.1007/s12185-012-1044-7

    DO - 10.1007/s12185-012-1044-7

    M3 - Article

    C2 - 22403058

    AN - SCOPUS:84862897867

    VL - 95

    SP - 577

    EP - 580

    JO - International Journal of Hematology

    JF - International Journal of Hematology

    SN - 0925-5710

    IS - 5

    ER -